Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in c-Met-based dual inhibitors in the treatment of cancers
Fanqi Jin, Yi‐Han Lin, Yuan Weidong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116477-116477
Closed Access | Times Cited: 9

Showing 9 citing articles:

Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights
Wagdy M. Eldehna, Haytham O. Tawfik, Maha-Hamadien Abdulla, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107804-107804
Closed Access | Times Cited: 2
Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents
Bassem H. Naguib, Heba A. Elsebaie, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107682-107682
Closed Access | Times Cited: 1
Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytes
Claudia Mittendorff, Issam Abu-Taha, Lena Kassler, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access | Times Cited: 1
The MET Oncogene: An Update on Targeting Strategies
Simona Gallo, Consolata Beatrice Folco, Tiziana Crepaldi
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1473-1473
Open Access | Times Cited: 1
Design, synthesis, biological evaluation, and docking studies of novel triazolo[4,3-b]pyridazine derivatives as dual c-Met/Pim-1 potential inhibitors with antitumor activity
Mohamed E. Mahmoud, Eman Ahmed, Hamdy M. Ragab, et al.
RSC Advances (2024) Vol. 14, Iss. 41, pp. 30346-30363
Open Access
Targeting DNA damage response in pancreatic ductal adenocarcinoma: A review of preclinical and clinical evidence
Fatemeh Moosavi, Bahareh Hassani, Somayeh Nazari, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189185-189185
Closed Access
Recent advances in the treatment of non-small cell lung cancer with MET inhibitors
Dongna Zhang, Wenying Zhang, He Liu, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access
Advances in Selective c-MET Kinase Inhibitors: Application of Fused [5,6]-Bicyclic Nitrogen-Containing Cores for Anticancer Drug Design
Mehdi Valipour, Zahra Zakeri Khatir, Adileh Ayati, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117177-117177
Closed Access
The MET Oncogene Network of Interacting Cell Surface Proteins
Simona Gallo, Consolata Beatrice Folco, Tiziana Crepaldi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13692-13692
Open Access
Page 1

Scroll to top